JR

Jangi Reddy Kankanala

Active Director Director DIN 02118254
DIN 02118254 First appointment Mar 2003 Primary industry Life Sciences
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Mar 2003
Shareholding value •••• Premium profile

About Jangi Reddy Kankanala

Data last updated:

Jangi Reddy Kankanala is a Director at Palamur Biosciences Private Limited (since 2009), Director at Palamur Genetics Services Private Limited (since 2003) and Director at Kbr & Sons Healthcare Private Limited (since 2012). The companies operate in Life Sciences, Healthcare and Manufacturing. The 3 current companies with reported revenue have a combined latest revenue of ₹120 Cr; the largest is Palamur Biosciences Private Limited at ₹60.63 Cr (FY 2023). Earlier, Jangi Reddy Kankanala was a Director at Rajvir Industries Limited (2006–2012) and Designated Partner at Inhouse Property Management Llp (from 2013).

DIN 02118254
Primary Designation Director
Industry Life Sciences
First Appointment 01 Mar 2003
Oldest Company Age 28 yrs
Largest company Palamur Biosciences Private Limited · ₹60.63 Cr (FY 2023)
Combined revenue ₹120 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Palamur Biosciences Private Limited U01403TG2008PTC059829
Director19 Feb 20092008₹60.63 Cr (FY 2023)Active
Director01 Mar 20031998₹58.96 Cr (FY 2025)Active
Director23 May 20122012₹77.9 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rajvir Industries Limited L17116TG2004PLC044053
Director31 Oct 20062004₹6.59 Cr (FY 2023)Active
Designated Partner06 Feb 20132013Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Palamur Biosciences Private Limited
Palamur Genetics Services Private Limited
Kbr & Sons Healthcare Private Limited
Inhouse Property Management Llp
Premium access

Shareholding and investment profile for Jangi Reddy Kankanala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jangi Reddy Kankanala

Jangi Reddy Kankanala currently holds 3 directorships: Palamur Biosciences Private Limited (Director, since 19 Feb 2009, revenue ₹60.63 Cr (FY 2023)); Palamur Genetics Services Private Limited (Director, since 01 Mar 2003, revenue ₹58.96 Cr (FY 2025)); Kbr & Sons Healthcare Private Limited (Director, since 23 May 2012, revenue ₹77.9 Lakh (FY 2025)).

Jangi Reddy Kankanala was first appointed on 01 Mar 2003 as Director at Palamur Genetics Services Private Limited. The most recent appointment on record is 06 Feb 2013 at Inhouse Property Management Llp.

The 3 current companies of Jangi Reddy Kankanala that report revenue have a combined latest revenue of ₹120 Cr: Palamur Biosciences Private Limited ₹60.63 Cr (FY 2023); Palamur Genetics Services Private Limited ₹58.96 Cr (FY 2025); Kbr & Sons Healthcare Private Limited ₹77.9 Lakh (FY 2025).

Jangi Reddy Kankanala held 2 earlier board appointments: Rajvir Industries Limited (Director, 31 Oct 2006 to 22 Mar 2012); Inhouse Property Management Llp (Designated Partner, from 06 Feb 2013).

The current boards of Jangi Reddy Kankanala's companies include Krishna Reddy Kankanala (Palamur Biosciences Private Limited), Subhashini Vijayaragavan (Palamur Biosciences Private Limited), Venkat Reddy Kankanala (Palamur Biosciences Private Limited), Vijayaragavan Thiruvengadam (Palamur Biosciences Private Limited), Ram Reddy Kankanala (Kbr & Sons Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available